Top Tweets for #angiosarcomas
Stefania Kokkali presenting the current knowledge on adjuvant and neoadjuvant treatment of #Angiosarcomas
#esmorarecancers25 #sarcoma

π§¬POT1 is a component of the shelterin complex involved in telomere maintenance.
π° This work just published in @CCR_AACR uncovers that nearly 50% of cardiac #angiosarcomas have mutations in POT1, and likely most of them are of #germline origin
https://t.co/0OkOzS8DtX
#Alliance A091902 study presented by Dr. Juneko Grilley-Olsen of #paclitaxel vs #paclitaxel+nivolumab. Compelling data for #scalp #angiosarcomas but no obvious improvement of the combo over paclitaxel alone in overall population. More work necessary. #ASCO24 #CTOSTweeTOS

Dr Kim from #DongA University in π°π· presented their #investigator-initiated study for anti-PDL1 #avelumab with #paclitaxel in #angiosarcomas. ORR 50%! Look at that waterfall plot! π #sarcomas #ASCO24 @CTOsTweeTOS

π¨Meet the Lab!
Iβm Sara (@sara_arfan), a PhD student @ICR_London funded by @Sarcoma_UK.
I focus on the molecular and immune characterisation of #angiosarcomas, one of the most aggressive #sarcomas, by using proteomics and transcriptomics to identify new drugs & biomarkers.

In this study, researchers queried the Surveillance, Epidemiology, and End Result (SEER) database for incidences of both primary (PBA) and secondary (SBA) #breast #angiosarcomas between 1992 and 2016. The authors found that the incidence of SBA occurring after a primary breast cancer diagnosis increased 3-fold during the study period. These findings suggest that SBA risk is an important consideration in the shared decision making for treatment and management of primary breast cancer. https://t.co/MVoEZUGYsK

#Angiosarcomas are vascular #sarcomas with poor outcomes. We compare the Protein vs RNA levels in these tumours & show that only 20% are correlated
In fact, candidate prognostic biomarkers at the protein & RNA levels rarely overlap
π’Take home message: Protein β RNA. 5/n

πͺπ¬Courage and trust in medical research: welcome to the newborn "Sofia nel cuore" association created by Sofia Sacchitelli with the mission of supporting ISG research studies on #angiosarcomas !π«Ά #SofiaNelCuore #sarcoma
@SilviaStacchia @FedeNavarria
Dal desiderio di Sofia Sacchitelli, studentessa di medicina, malata di angiosarcoma cardiaco, a #Genova nasce l'associazione #Sofianelcuore per finanziare studi e nuove terapie. #ioseguotgr #tgrliguria #sofianelcuore https://t.co/TU2rh3lIxV
Clinical, genomic, transcriptomic correlates of response to ICB in #angiosarcomas Another example of their heterogeneity. https://t.co/BeW66rAFi6
Not all #sarcomas are the same. Not all #angiosarcomas are the same. @AndreaEspejoMD found H&N tumors harbor an #Immunotherapy profile supporting further study IO in this population:
https://t.co/HXiFJTAlYh
New review on Clinical Management and Molecular Biology of #Angiosarcomas in @Cancers_MDPI from the team!
Great collaboration with @saxotomy, @RobinL_Jones, & @JessieAmyB. Read it here: https://t.co/igZamxwKUV #Sarcoma

EDITORIAL: Regional Lymph Nodes in #ScalpAngiosarcomas: The Hidden Harbinger of Doom? #angiosarcomas https://t.co/tYxtp7Gs5t @McMastersKelly @SocSurgOnc
Congrats @JoeyZhangYJ! Great work on establishing a #synergistic role for #HDACinhibitors and #cytotoxics in the treatment of #angiosarcomas! I think this can form the basis of a human clinical trial! #sarcomas #CUHKSarcoma @CUHKofficial
#AACR20 #Eposter sessions. Nice end of my Mphil work and a good start of phd study. Always thanks a lot for my supervisor's support. @herbloong

Thanks @vinodravi for leadership in this int'l trial for a rare disease! Amazing responses seen in #cutaneous #angiosarcomas. Thankful to be able to contribute. Shout out to other investigators including @saxotomy & PIs of upcoming new sites! @CUHKMedicine #CUHKSarcoma #ASCO20
Oraxol + Encequidar in Angiosarcoma: Response rate of 50%, Stable disease 50%. This investigator initiated study that started at MD Anderson is now open globally. A big thank you to OUR PATIENTS, investigators and Sarcoma team! https://t.co/Fp9DxReRCH

Congrats to @JoeyZhangYJ for having further updated her #MPhil work on #synergism of #cytotoxics and #HDACinhibition in #cutaneous #angiosarcomas accepted at @AACR #AACR20! Come by & take a look if you are in San Diego! @CUHKMedicine #CUHKSarcoma #sarcoma #mentorship #towardsPhD

Although not very common, radiation-induced #sarcomas can happen after breast cancer radiotherapy. Most of these are #angiosarcomas, but as this article discusses, #leiomyosarcoma can also occur. https://t.co/1QrLjERysi
Our #MPhil student @JoeyZhangYJ presented her work on potential #synergism of #histonedeacetylase (#HDAC) #inhibition & #cytotoxics as novel Tx in #cutaneous #angiosarcomas during #postgraduate #research seminar. Well done! #CUHKSarcoma @CUHKMedicine #sarcoma @CUHKMedicine

@oncologician @SABCSSanAntonio We are involved in the pilot study with the same #oral #paclitaxel #ORAXOL compound in #cutaneous #angiosarcomas. Recruitment is near completion with exciting results soon to follow! @CUHKMedicine #CUHKSarcoma @AthenexInc @AthenexOncology
Thanks @sprakermdphd! We were surprised by the results of our study led by @DMitra_MD & will be treating more scalp/face #angiosarcomas w/ VMAT.
Great initial results for your clinical trial w/ chemoRT. Agree we need to continue to improve outcomes for these patients!
#CTOS2019
.@mirandalammd from @BrighamWomens delivered an excellent talk today about their evolving strategy for treating H&N #angiosarcoma
VMAT dosimetry much better than brachytherapy
Any technique is allowed on our trial, but I prefer VMAT too (or electrons for flat sites) #CTOS2019
Congrats @JoeyZhangYJ for presenting her #MPhil work on #synergistic activities of #HDAC inhibition & #cytotoxics in #cutaneous #angiosarcomas. Found synergism % #doxorubicin & #panobinostat - worthy candidates for future trials. #CUHKSarcoma @CUHKMedicine @ctosociety #CTOS2019

Last Seen Hashtags on Sotwe
snapchat(******()***)()filter:videos
Seen from Brazil
flaites #gay
Seen from Chile
egecuckold
Seen from Turkey
minichat((((*))))* filter:videos
Seen from Mexico
lovedolltoyfactory
Seen from Canada
ncfreak
Seen from United States
MGAI
Seen from Netherlands
XdinaryHeroes
Seen from United States
minichatt(**)(**(**(*(*)**)*)*) + filter:native_video
daksorjuts
Seen from Thailand
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.5M followers

Barack Obama 
@barackobama
118.8M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.3M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.5M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.5M followers

Bill Gates 
@billgates
65.3M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.2M followers

CNN 
@cnn
61.7M followers

X 
@x
60.7M followers

























